This compound is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is a quinazoline derivative with a complex structure that includes an amide, amine, and ether functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2475094-87-0
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
Afatinib impurity reference standard
(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
active pharmaceutical ingredient impurity
Afatinib Impurity 18
Pharmaceutical impurity reference standard
Afatinib D6
active pharmaceutical ingredient
(-)-Epiafzelechin
active pharmaceutical ingredient (API) standard
Prasteronyl Abiraterone
active pharmaceutical ingredient
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Beta-Epoxyabiraterone acetate
Active pharmaceutical ingredient for cancer
(E)-N-[4-(4-chloro-3-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
CIGJZGGVLAOLAG-CWDCEQMOSA-N
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)F)O[C@H]4CCOC4